Published in Medical Letter on the CDC and FDA, September 7th, 2003
Researchers suggest that by misleading consumers, the web sites could be in violation of truth-in-advertising standards.
"In our study we clearly document the need to change the way ephedra products are advertised," said Bimal Ashar, MD, assistant professor of medicine at the Johns Hopkins University School of Medicine and senior author of the study, which appeared in Mayo Clinic...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.